Fantastic private eye work! I have been trying to
Post# of 148292
Here's what the head of ARO, Dr. Otavio Berwanger, Linkedin posted about a Pfizer trial 8 months ago:
Our STOP-COVID Trial just published in the NEJM. Great collaboration between ARO Einstein, Pfizer and incredible sites ! Among patients hospitalized with Covid-19 pneumonia, tofacitinib led to a lower risk of death or respiratory failure through day 28 than placebo. Above all, great team work !Patricia Guimaraes, MD
So let's hope that BP is not in play here.